日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

TP53 mutation is associated with improved disease control in patients with advanced RAS wild-type colorectal adenocarcinoma treated with cetuximab and pembrolizumab

TP53 突变与接受西妥昔单抗和帕博利珠单抗治疗的晚期 RAS 野生型结直肠腺癌患者的疾病控制改善相关

Fountzilas, Christos; Rosario, Spencer; Witkiewicz, Agnieszka K; Withers, Henry G; Bajor, David L; Mukherjee, Sarbajit; Saltzman, Joel; Maguire, Orla; Minderman, Hans; Chatley, Sarah; Tarquini, Mary Lynn; Whitworth, Amy; Jurcevic, Jennifer; Hsiao, Hua-Hsin; Knudsen, Erik S; Muhitch, Jason B; Abrams, Scott I; Kalinski, Pawel; Segal, Brahm H; Bakin, Andrei; Yuan, Guangwei; Wang, Chong; Attwood, Kristopher; Iyer, Renuka; Boland, Patrick M

Comprehensive tumor-immune profiling reveals mediators of paradoxical immune sensitivity in sarcomatoid renal cell carcinoma

全面的肿瘤免疫分析揭示了肉瘤样肾细胞癌中矛盾免疫敏感性的介质

Nicholas J Salgia ,Adil Khan ,Wilhelm M Aubrecht ,Gavin C Twoey ,Jacky Chow ,Kristopher Attwood ,Han Yu ,Jessie L Chiello ,Nathaniel Hansen ,Brianna J Wasik ,Benjamin D Mercier ,Hedyeh Ebrahimi ,Luis Meza ,Orla Maguire ,Michalis Mastri ,Cassandra Whalen ,Hans Minderman ,Patrick Pirrotte ,Sara Byron ,Elizabeth A Repasky ,Prashant K Singh ,Wiam Bshara ,Jianmin Wang ,A J Robert McGray ,Scott I Abrams ,Bo Xu ,Kevin H Eng ,Mark D Long ,Sumanta K Pal ,Eric C Kauffman ,Jason B Muhitch

Plant-based diet, inflammation biomarkers and body composition among women with breast cancer: the Pathways Study

植物性饮食、炎症生物标志物和身体成分与乳腺癌女性的关系:通路研究

Cheng, En; Hong, Chi-Chen; Ergas, Isaac J; Caan, Bette J; Kwan, Marilyn L; Roh, Janise M; Cheng, Ting-Yuan David; Sharma, Nitika J; Hanson, Joseph R; Minderman, Hans; Sheng, Haiyang; Yao, Song; Iyengar, Neil M; Ambrosone, Christine B; Kushi, Lawrence H; Cespedes Feliciano, Elizabeth M

NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs

NK受体信号传导降低TCR激活阈值,增强TAA特异性CTL对癌细胞的选择性识别

Bowen Dong ,Nataša Obermajer ,Takemasa Tsuji ,Junko Matsuzaki ,Cindy M Bonura ,Cindy Sander ,Henry Withers ,Mark D Long ,Colin Chavel ,Scott H Olejniczak ,Hans Minderman ,John M Kirkwood ,Robert P Edwards ,Walter J Storkus ,Pedro Romero ,Pawel Kalinski

Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features.

鼻窦弥漫性大B细胞淋巴瘤:分子谱分析可识别具有独特预后和可靶向遗传特征的亚型

Eriksen Patrick R G, de Groot Fleur, Clasen-Linde Erik, de Nully Brown Peter, de Groen Ruben, Melchior Linea C, Maier Andrea D, Minderman Marthe, Vermaat Joost S P, von Buchwald Christian, Pals Steven T, Heegaard Steffen

Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study

半乳糖凝集素-3预测减低强度异基因造血干细胞移植后急性移植物抗宿主病和总体死亡率:一项BMT-CTN生物样本库研究

McCarthy, Philip L; Attwood, Kristopher M; Liu, Xiaojun; Chen, George L; Minderman, Hans; Alousi, Amin; Bashey, Asad; Lowsky, Robert; Miklos, David B; Hansen, John; Westervelt, Peter; Yanik, Gregory; Waller, Edmund K; Howard, Alan; Blazar, Bruce R; Wallace, Paul K; Reshef, Ran; Horowitz, Mary M; Maziarz, Richard T; Levine, John E; Mohammadpour, Hemn

Immune Cell Molecular Pharmacodynamics of Lanreotide in Relation to Treatment Response in Patients with Gastroenteropancreatic Neuroendocrine Tumors

兰瑞肽免疫细胞分子药效学与胃肠胰神经内分泌肿瘤患者治疗反应的关系

Sabah Alaklabi, Orla Maguire, Harsha Pattnaik, Yali Zhang, Jacky Chow, Jianmin Wang, Hans Minderman, Renuka Iyer

The oncogenic human B-cell lymphoma MYD88 L265P mutation genocopies activation by phosphorylation at the Toll/interleukin-1 receptor (TIR) domain

致癌人类 B 细胞淋巴瘤 MYD88 L265P 突变通过 Toll/白细胞介素-1 受体 (TIR) 结构域的磷酸化进行基因复制激活

Marthe Minderman, Hildo Lantermans, Carmen van der Zwaan, Arie J Hoogendijk, Maartje van den Biggelaar, Marie José Kersten, Marcel Spaargaren #, Steven T Pals #

MALT1-dependent cleavage of CYLD promotes NF-κB signaling and growth of aggressive B-cell receptor-dependent lymphomas

MALT1 依赖的 CYLD 裂解促进 NF-κB 信号传导和侵袭性 B 细胞受体依赖性淋巴瘤的生长

Marthe Minderman, Hildo C Lantermans, Leonie J Grüneberg, Saskia A G M Cillessen, Richard J Bende, Carel J M van Noesel, Marie José Kersten, Steven T Pals #, Marcel Spaargaren #

Systemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor microenvironments for selective CTL influx

乳腺癌患者全身输注 TLR3 配体和 IFN-α 可重新编程局部肿瘤微环境,以实现选择性 CTL 流入

Shipra Gandhi, Mateusz Opyrchal, Melissa J Grimm, Ronald T Slomba, Kathleen M Kokolus, Agnieszka Witkiewicz, Kristopher Attwood, Adrienne Groman, Lauren Williams, Mary Lynne Tarquini, Paul K Wallace, Kah Teong Soh, Hans Minderman, Orla Maguire, Tracey L O'Connor, Amy P Early, Ellis G Levine, Pawel K